Muhammad Irfanur Rashid

Muhammad Irfanur Rashid

Auto-generated profile, based on publicly available information

Muhammad Irfanur Rashid

Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2025 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
SNSeitaro Nakamura
Seitaro Nakamura
YKYuhei Kamei
Yuhei Kamei
AMAyumu Matsushima
Ayumu Matsushima
KYKazuki Yamamoto
Kazuki Yamamoto
HAHirokazu Akiyama
Hirokazu Akiyama
KSKazunori Shimizu
Kazunori Shimizu

13 December 2025 in bioRxiv
Verified
Preprint
Open access
KOKazunari Onodera
Kazunari Onodera
YRYuichi Riku
Yuichi Riku
DSDaisuke Shimojo
Daisuke Shimojo
AOAkinobu Ota
Akinobu Ota
MRMuhammad Irfanur Rashid
Muhammad Irfanur Rashid
Yohei OkadaYohei Okada
Yohei Okada
Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disorder caused by the expansion of the polyglutamine tract in the androgen receptor (AR). Motor neurons (MNs) derived from patient-specific induced pluripotent stem cells (iPSCs) robustly recapitulated early SBMA phenotypes driven by endogenous mutant AR in the absence of testosterone (dihydrotestosterone) and detectable mutant AR aggregation. Notably, endoplasmic reticulum stress markedly exacerbated SBMA pathology. Cross-species integrative analyses of patient-derived neurons and spinal cords of transgenic mouse models revealed high expression of multiple disease-associated neuropeptides, including urotensin II (UTS2), in patient spinal MNs that was correlated with disease onset and progression in iPSC-derived MNs. Downstream signaling analyses of these neuropeptides revealed convergent molecular pathways whose pharmacological inhibition rescued cellular phenotypes. Together, these results establish a human disease model harboring endogenous mutant AR that closely reproduces early SBMA pathology and provides molecular leads for elucidating disease mechanisms and biomarkers and developing therapeutic targets.

15 October 2026 in Stem Cell Reports
Verified
Journal Article
Open access
MRMuhammad Irfanur Rashid
Muhammad Irfanur Rashid
JKJames Kiley
James Kiley
KAKarim Azzag
Karim Azzag
SCSarah B. Crist
Sarah B. Crist
EMEthan Murphy
Ethan Murphy
RPRita Perlingeiro
Rita Perlingeiro
Cell-based regenerative therapies represent a promising platform for muscular dystrophies, but the role of histocompatibility for muscle engraftment remains poorly defined. Given their close genetic relationship to humans, nonhuman primate (NHP) models provide an ideal system to investigate this question. Here, we generated myogenic progenitors from induced pluripotent stem cell (iPSC) lines derived from five major histocompatibility complex (MHC)-typed Mauritian-origin cynomolgus macaques (MCMs). Following extensive characterization, one iPSC clone from each donor was selected for transplantation across distinct MHC matching conditions, including fully matched, partially matched, and mismatched recipient-donor pairs. We found that variation in regenerative potential was primarily donor-intrinsic. Strikingly, fully mismatched donor-derived myogenic progenitors exhibiting high regenerative potential consistently outperformed partially and fully matched grafts across recipients. Our results suggest that, under clinically relevant immunosuppression, donor-intrinsic regenerative potential may outweigh histocompatibility as a determinant of early skeletal muscle engraftment, supporting the development of broadly applicable off-the-shelf allogeneic iPSC-based therapies for muscular dystrophies.